Human Genome Epidemiology Literature Finder
Records 1 - 30 (of 30 Records) |
Query Trace: Abnormalities and SRSF2[original query] |
---|
Genetic analysis of patients with leukemic transformation of myeloproliferative neoplasms shows recurrent SRSF2 mutations that are associated with adverse outcome. Blood 2012 May 119 (19): 4480-5. Zhang Su-Jiang, Rampal Raajit, Manshouri Taghi, Patel Jay, Mensah Nana, Kayserian Andrew, Hricik Todd, Heguy Adriana, Hedvat Cyrus, Gönen Mithat, Kantarjian Hagop, Levine Ross L, Abdel-Wahab Omar, Verstovsek Srd |
A compendium of cytogenetic abnormalities in myelofibrosis: molecular and phenotypic correlates in 826 patients. British journal of haematology 2015 Apr 169 (1): 71-6. Wassie Emnet, Finke Christy, Gangat Naseema, Lasho Terra L, Pardanani Animesh, Hanson Curtis A, Ketterling Rhett P, Tefferi Ayal |
Next-generation sequencing of acute myeloid leukemia identifies the significance of TP53, U2AF1, ASXL1, and TET2 mutations. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2015 May 28 (5): 706-14. Ohgami Robert S, Ma Lisa, Merker Jason D, Gotlib Jason R, Schrijver Iris, Zehnder James L, Arber Daniel |
Investigation of 305 patients with myelodysplastic syndromes and 20q deletion for associated cytogenetic and molecular genetic lesions and their prognostic impact. British journal of haematology 2014 Mar 164 (6): 822-33. Bacher Ulrike, Haferlach Torsten, Schnittger Susanne, Zenger Melanie, Meggendorfer Manja, Jeromin Sabine, Roller Andreas, Grossmann Vera, Krauth Maria-Theresa, Alpermann Tamara, Kern Wolfgang, Haferlach Claud |
Impact of TET2, SRSF2, ASXL1 and SETBP1 mutations on survival of patients with chronic myelomonocytic leukemia. Experimental hematology & oncology 2015 4 14. Cui Yajuan, Tong Hongyan, Du Xin, Li Bing, Gale Robert Peter, Qin Tiejun, Liu Jinqin, Xu Zefeng, Zhang Yue, Huang Gang, Jin Jie, Fang Liwei, Zhang Hongli, Pan Lijuan, Hu Naibo, Qu Shiqiang, Xiao Zhiji |
CHFR hypermethylation, a frequent event in acute myeloid leukemia, is independently associated with an adverse outcome. Genes, chromosomes & cancer 2015 Nov . Gao Li, Liu Fang, Zhang Hui, Sun Junzhong, Ma Yig |
Targeted deep sequencing improves outcome stratification in chronic myelomonocytic leukemia with low risk cytogenetic features. Oncotarget 2016 Jul . Palomo Laura, Garcia Olga, Arnan Montse, Xicoy Blanca, Fuster Francisco, Cabezón Marta, Coll Rosa, Ademà Vera, Grau Javier, Jiménez Maria-José, Pomares Helena, Marcé Sílvia, Mallo Mar, Millá Fuensanta, Alonso Esther, Sureda Anna, Gallardo David, Feliu Evarist, Ribera Josep-Maria, Solé Francesc, Zamora Lurd |
Response to 5-azacytidine in a patient with TET2-mutated angioimmunoblastic T-cell lymphoma and chronic myelomonocytic leukaemia preceded by an EBV-positive large B-cell lymphoma. Hematological oncology 2016 Jun . Saillard Colombe, Guermouche Helene, Derrieux Coralie, Bruneau Julie, Frenzel Laurent, Couronne Lucile, Asnafi Vahid, Macintyre Elizabeth, Trinquand Amélie, Lhermitte Ludovic, Molina Thierry, Suarez Felipe, Lemonnier Francois, Kosmider Olivier, Delarue Richard, Hermine Olivier, Cheminant Morga |
Mastocytosis among elderly patients: A multicenter retrospective French study on 53 patients. Medicine 2016 Jun 95 (24): e3901. Rouet Audrey, Aouba Achille, Damaj Gandhi, Soucié Erinn, Hanssens Katia, Chandesris Marie-Olivia, Livideanu Cristina Bulai, Dutertre Marine, Durieu Isabelle, Grandpeix-Guyodo Catherine, Barète Stéphane, Bachmeyer Claude, Soria Angèle, Frenzel Laurent, Fain Olivier, Grosbois Bernard, de Gennes Christian, Hamidou Mohamed, Arlet Jean-Benoit, Launay David, Lavigne Christian, Arock Michel, Lortholary Olivier, Dubreuil Patrice, Hermine Olivier, Georgin-Lavialle Soph |
Epidemiology and clinical relevance of mutations in postpolycythemia vera and postessential thrombocythemia myelofibrosis: A study on 359 patients of the AGIMM group. American journal of hematology 2016 Apr . Rotunno Giada, Pacilli Annalisa, Artusi Valentina, Rumi Elisa, Maffioli Margherita, Delaini Federica, Brogi Giada, Fanelli Tiziana, Pancrazzi Alessandro, Pietra Daniela, Bernardis Isabella, Belotti Clara, Pieri Lisa, Sant'Antonio Emanuela, Salmoiraghi Silvia, Cilloni Daniela, Rambaldi Alessandro, Passamonti Francesco, Barbui Tiziano, Manfredini Rossella, Cazzola Mario, Tagliafico Enrico, Vannucchi Alessandro M, Guglielmelli Pao |
RUNX1 mutations in acute myeloid leukemia are associated with distinct clinico-pathologic and genetic features. Leukemia 2016 May . Gaidzik V I, Teleanu V, Papaemmanuil E, Weber D, Paschka P, Hahn J, Wallrabenstein T, Kolbinger B, Köhne C-H, Horst H A, Brossart P, Held G, Kündgen A, Ringhoffer M, Götze K, Rummel M, Gerstung M, Campbell P, Kraus J M, Kestler H A, Thol F, Heuser M, Schlegelberger B, Ganser A, Bullinger L, Schlenk R F, Döhner K, Döhner |
Genetic Risk Assessment in Myeloproliferative Neoplasms. Mayo Clinic proceedings 2017 8 92 (8): 1283-1290. Tefferi Ayalew, Vannucchi Alessandro Mar |
Impact of mutational studies on the diagnosis and the outcome of high-risk myelodysplastic syndromes and secondary acute myeloid leukemia patients treated with 5-azacytidine. Oncotarget 2018 Apr 9 (27): 19342-19355. Cabezón Marta, Bargay Joan, Xicoy Blanca, García Olga, Borrás Josep, Tormo Mar, Marcé Sílvia, Pedro Carme, Valcárcel David, Jiménez Maria-José, Guàrdia Ramón, Palomo Laura, Brunet Salut, Vall-Llovera Ferran, Garcia Antoni, Feliu Evarist, Zamora Lurdes, |
Momelotinib therapy for myelofibrosis: a 7-year follow-up. Blood cancer journal 2018 3 8 (3): 29. Tefferi Ayalew, Barraco Daniela, Lasho Terra L, Shah Sahrish, Begna Kebede H, Al-Kali Aref, Hogan William J, Litzow Mark R, Hanson Curtis A, Ketterling Rhett P, Gangat Naseema, Pardanani Anime |
The mutational landscape of accelerated- and blast-phase myeloproliferative neoplasms impacts patient outcomes. Blood advances 2018 10 2 (20): 2658-2671. McNamara Caroline J, Panzarella Tony, Kennedy James A, Arruda Andrea, Claudio Jaime O, Daher-Reyes Georgina, Ho Jenny, Siddiq Nancy, Devlin Rebecca, Tsui Hubert, Su Jie, Stockley Tracy, Sukhai Mahadeo, Kanwar Nisha, Chan Steven, Maze Dawn, Schimmer Aaron, Schuh Andre, Sibai Hassan, Viswabandya Auro, Yee Karen, Minden Mark D, Kamel-Reid Suzanne, Gupta Vik |
Ring sideroblasts in chronic phase of polycythemia vera identifies a subset of patients with an increased risk of progression to blast phase. Annals of diagnostic pathology 2019 4 40 45-48. Hidalgo-Lopez Juliana E, Kanagal-Shamanna Rashmi, Reyes Steven, Zhao Chong, Medeiros L Jeffrey, Bueso-Ramos Carlos |
Clonal myelopoiesis in the UK Biobank cohort: ASXL1 mutations are strongly associated with smoking.
Leukemia 2020 Oct 34 (10): 2660-2672. Dawoud Ahmed A Z, Tapper William J, Cross Nicholas C |
[Correlation between U2AF1 Gene Mutation Characteristics and Clinical Manifestations and Prognosis in Patients with Myelodysplastic Syndrome]. Zhongguo shi yan xue ye xue za zhi 2020 Dec 28 (6): 1977-1984. Zhao Wen-Shu, Zhang Yin-Tian, Jiang Qian-Li, Liu Qi-Fa, Dai M |
Cytogenetic and molecular landscape and its potential clinical significance in Hispanic CMML patients from Puerto Rico. Oncotarget 2020 12 11 (47): 4411-4420. Jiang Zeju, Sun Xinlai, Wu Zhao, Alhatem Albert, Zheng Ruifang, Liu Dongfang, Wang Yaqun, Kumar Dibyendu, Xia Changqing, You Bei, Wang He, Liu Chen, Jiang Jie-G |
Features and impacts on the prognosis of gene mutations in patients with acute myeloid leukemia. Neoplasma 2021 5 68 (5): 1072-1078. Wu Ming, Guo Zi-Wen, Huang Gui-Nian, Ye Yong-B |
Mutations in chronic myelomonocytic leukemia and their prognostic relevance. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2021 4 23 (9): 1731-1742. Jian J, Qiao Y, Li Y, Guo Y, Ma H, Liu |
Cytogenetic and molecular aberrations and worse outcome for male patients in systemic mastocytosis. Theranostics 2021 1 11 (1): 292-303. Kluin-Nelemans Hanneke C, Jawhar Mohamad, Reiter Andreas, van Anrooij Bjorn, Gotlib Jason, Hartmann Karin, Illerhaus Anja, Oude Elberink Hanneke N G, Gorska Aleksandra, Niedoszytko Marek, Lange Magdalena, Scaffidi Luigi, Zanotti Roberta, Bonadonna Patrizia, Perkins Cecelia, Elena Chiara, Malcovati Luca, Shoumariyeh Khalid, von Bubnoff Nikolas, Müller Sabine, Triggiani Massimo, Parente Roberta, Schwaab Juliana, Kundi Michael, Fortina Anna Belloni, Caroppo Francesca, Brockow Knut, Zink Alexander, Fuchs David, Angelova-Fischer Irena, Yavuz Akif Selim, Doubek Michael, Mattsson Mattias, Hagglund Hans, Panse Jens, Simonowski Anne, Sabato Vito, Schug Tanja, Jentzsch Madlen, Breynaert Christine, Várkonyi Judit, Kennedy Vanessa, Hermine Olivier, Rossignol Julien, Arock Michel, Valent Peter, Sperr Wolfgang |
Clonal cytopenia of undetermined significance (CCUS) with dysplasia is enriched for MDS-type molecular findings compared to CCUS without dysplasia. European journal of haematology 2021 1 106 (4): 500-507. Jajosky Audrey N, Sadri Navid, Meyerson Howard J, Oduro Kwadwo A, Kelkar Ashwin, Fitzgerald Brynn, Tomlinson Benjamin, Moore Erika M, Beck Rose |
Genetic Characteristics According to Subgroup of Acute Myeloid Leukemia with Myelodysplasia-Related Changes. Journal of clinical medicine 2022 5 11 (9): . Kang Dain, Jung Jin, Park Silvia, Cho Byung-Sik, Kim Hee-Je, Kim Yeojae, Lee Jong-Mi, Kim Hoon Seok, Ahn Ari, Kim Myungshin, Kim Yongg |
Therapy-related myeloid neoplasms with normal karyotype show distinct genomic and clinical characteristics compared to their counterparts with abnormal karyotype. British journal of haematology 2022 3 197 (6): 736-744. Tariq Hamza, Barnea Slonim Liron, Coty Fattal Zachary, Alikhan Mir B, Segal Jeremy, Gurbuxani Sandeep, Helenowski Irene B, Zhang Hui, Sukhanova Madina, Lu Xinyan, Altman Jessica K, Chen Qing C, Behdad Am |
Cytogenetic abnormalities in essential thrombocythemia: Clinical and molecular correlates and prognostic relevance in 809 informative cases. Blood cancer journal 2022 3 12 (3): 44. Gangat Naseema, Jadoon Yamna, Szuber Natasha, Hanson Curtis A, Wolanskyj-Spinner Alexandra P, Ketterling Rhett P, Pardanani Animesh, Tefferi Ayal |
Coexistence of Chronic Myelomonocytic Leukemia and Ulcerative Colitis With Rapid Progression to Acute Myelomonocytic Leukemia: A Case Report. Cureus 2022 3 14 (2): e22422. Pelkey Lauren J, Graham David M, Zakem Michael H, Muza-Moons Michelle |
Chronic myelomonocytic leukemia: 2022 update on diagnosis, risk stratification, and management. American journal of hematology 2022 1 97 (3): 352-372. Patnaik Mrinal M, Tefferi Ayal |
Reliability of flow-cytometry in diagnosis and prognostic stratification of myelodysplastic syndromes: correlations with morphology and mutational profile. Annals of hematology 2023 8 . Luca Guarnera, Emiliano Fabiani, Cristina Attrotto, Hajro Hajrullaj, Antonio Cristiano, Roberto Latagliata, Susanna Fenu, Francesco Buccisano, Maria Irno-Consalvo, Consuelo Conti, Maria Teresa Voso, Luca Mauril |
Sex Disparities in Myelodysplastic Syndromes: Genotype, Phenotype, and Outcomes. Clinical lymphoma, myeloma & leukemia 2023 2 . Tinsley-Vance Sara M, Ali Najla Al, Ball Somedeb, Aguirre Luis E, Jain Akriti G, Hussaini Mohammad Omar, Chan Onyee, Kuykendall Andrew, Sweet Kendra, Lancet Jeffrey, Padron Eric, Sallman David A, Komrokji Rami |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 22, 2024
- Content source: